In the mouse melanoma model, however, α-PD-L1 alone administration only had minor impact on the rate of tumor growth, suggesting simple blockade of the immune checkpoint is insufficient to elicit a powerful anti-tumor immune response. Here, CD274 is linked to neoplasm.